Exact Mass: 403.1783
Exact Mass Matches: 403.1783
Found 500 metabolites which its exact mass value is equals to given mass value 403.1783
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Myxochelin B
A member of the class of benzamides obtained by formal condensation of the 1- and 6-amino groups of hexane-1,2,6-triamine with the carboxy groups from two molecules of 2,3-dihydroxybenzoic acid followed by reduction of the amide carbonyl at position 5 to a hydroxy group.
Amibegron
BENZOYLARGININE-2-NAPHTHYLAMIDE
Pitavastatin Lactone
Benzoyl-DL-arginine-naphthylamide
4-Cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl]pentanoic acid
5-(4-methoxyanilino)-5-oxo-3-(3,4,5-trimethoxyphenyl)pentanoic acid
12-(2-hydroxy-ethyl)-14xi-methyl-5,11,16-trioxo-(7xiH,12xiH,13xiH,15xiH)-1,2,15,20-tetrahydro-21-nor-seneciona-1(8),2-diene-13-carboxylic acid lactone|Inaepuidenine|Inaequidenin|inaequidenine
rel-(1S,2R,3aS,8S,10aR,10bR)-1-ethyl-3a,5,6,8,9,10,10a,10b-octahydro-4-methyl-8-[(2S,4S)-tetrahydro-4-methyl-5-oxofuran-2-yl]-5H-spiro[furan-2,2-furo[3,2-c]pyrrolo[1,2-a]azepine]-4,5(1H)-dione|stemonine
Benztropine Mesylate
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators Benztropine mesylate (Benzatropine mesylate) is an orally active centrally acting anticholinergic agent that can be used for Parkinson's disease research. Benztropine mesylate is an anti-histamine agent and a dopamine re-uptake inhibitor. Benztropine mesylate is also a human D2 dopamine receptor allosteric antagonist. Benztropine mesylate also has anti-CSCs (cancer stem cells) effects[1][2].
SR58611
CONFIDENCE standard compound; INTERNAL_ID 243; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7982; ORIGINAL_PRECURSOR_SCAN_NO 7980 CONFIDENCE standard compound; INTERNAL_ID 243; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8004; ORIGINAL_PRECURSOR_SCAN_NO 8002 CONFIDENCE standard compound; INTERNAL_ID 243; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8021; ORIGINAL_PRECURSOR_SCAN_NO 8019 CONFIDENCE standard compound; INTERNAL_ID 243; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8035; ORIGINAL_PRECURSOR_SCAN_NO 8032 CONFIDENCE standard compound; INTERNAL_ID 243; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8017; ORIGINAL_PRECURSOR_SCAN_NO 8015 CONFIDENCE standard compound; INTERNAL_ID 243; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8034; ORIGINAL_PRECURSOR_SCAN_NO 8030
Ala Ala Asp Lys
Ala Ala Asp Gln
Ala Ala Glu Asn
Ala Ala Gly Trp
Ala Ala Lys Asp
Ala Ala Asn Glu
Ala Ala Gln Asp
Ala Ala Trp Gly
Ala Cys Asn Pro
Ala Cys Pro Asn
Ala Asp Ala Lys
Ala Asp Ala Gln
Ala Asp Lys Ala
Ala Asp Gln Ala
Ala Glu Ala Asn
Ala Glu Gly Lys
Ala Glu Gly Gln
Ala Glu Lys Gly
Ala Glu Asn Ala
Ala Glu Gln Gly
Ala Gly Ala Trp
Ala Gly Glu Lys
Ala Gly Glu Gln
Ala Gly Lys Glu
Ala Gly Gln Glu
Ala Gly Trp Ala
Ala Ile Asn Ser
Ala Ile Ser Asn
Ala Lys Ala Asp
Ala Lys Asp Ala
Ala Lys Glu Gly
Ala Lys Gly Glu
Ala Leu Asn Ser
Ala Leu Ser Asn
Ala Asn Ala Glu
Ala Asn Cys Pro
Ala Asn Glu Ala
Ala Asn Ile Ser
Ala Asn Leu Ser
Ala Asn Pro Cys
Ala Asn Ser Ile
Ala Asn Ser Leu
Ala Asn Thr Val
Ala Asn Val Thr
Ala Pro Cys Asn
Ala Pro Asn Cys
Ala Gln Ala Asp
Ala Gln Asp Ala
Ala Gln Glu Gly
Ala Gln Gly Glu
Ala Gln Ser Val
Ala Gln Val Ser
Ala Ser Ile Asn
Ala Ser Leu Asn
Ala Ser Asn Ile
Ala Ser Asn Leu
Ala Ser Gln Val
Ala Ser Val Gln
Ala Thr Asn Val
Ala Thr Val Asn
Ala Val Asn Thr
Ala Val Gln Ser
Ala Val Ser Gln
Ala Val Thr Asn
Ala Trp Ala Gly
Ala Trp Gly Ala
Cys Ala Asn Pro
Cys Ala Pro Asn
Cys Gly Lys Pro
Cys Gly Pro Lys
Cys Gly Pro Gln
Cys Gly Gln Pro
Cys Lys Gly Pro
Cys Lys Pro Gly
Cys Asn Ala Pro
Cys Asn Pro Ala
Cys Pro Ala Asn
Cys Pro Gly Lys
Cys Pro Gly Gln
Cys Pro Lys Gly
Cys Pro Asn Ala
Cys Pro Gln Gly
Cys Gln Gly Pro
Cys Gln Pro Gly
Asp Ala Ala Lys
Asp Ala Ala Gln
Asp Ala Lys Ala
Asp Ala Gln Ala
Asp Gly Gly Arg
Asp Gly Asn Val
Asp Gly Arg Gly
Asp Gly Val Asn
Asp Lys Ala Ala
Asp Asn Gly Val
Asp Asn Val Gly
Asp Gln Ala Ala
Asp Arg Gly Gly
Asp Val Gly Asn
Asp Val Asn Gly
Glu Ala Ala Asn
Glu Ala Gly Lys
Glu Ala Gly Gln
Glu Ala Lys Gly
Glu Ala Asn Ala
Glu Ala Gln Gly
Glu Gly Ala Lys
Glu Gly Ala Gln
Glu Gly Lys Ala
Glu Gly Gln Ala
Glu Lys Ala Gly
Glu Lys Gly Ala
Glu Asn Ala Ala
Glu Gln Ala Gly
Glu Gln Gly Ala
Gly Ala Ala Trp
Gly Ala Glu Lys
Gly Ala Glu Gln
Gly Ala Lys Glu
Gly Ala Gln Glu
Gly Ala Trp Ala
Gly Cys Lys Pro
Gly Cys Pro Lys
Gly Cys Pro Gln
Gly Cys Gln Pro
Gly Asp Gly Arg
Gly Asp Asn Val
Gly Asp Arg Gly
Gly Asp Val Asn
Gly Glu Ala Lys
Gly Glu Ala Gln
Gly Glu Lys Ala
Gly Glu Gln Ala
Gly Gly Asp Arg
Gly Gly Arg Asp
Gly Ile Asn Thr
Gly Ile Gln Ser
Gly Ile Ser Gln
Gly Ile Thr Asn
Gly Lys Ala Glu
Gly Lys Cys Pro
Gly Lys Glu Ala
Gly Lys Pro Cys
Gly Leu Asn Thr
Gly Leu Gln Ser
Gly Leu Ser Gln
Gly Leu Thr Asn
Gly Asn Asp Val
Gly Asn Ile Thr
Gly Asn Leu Thr
Gly Asn Thr Ile
Gly Asn Thr Leu
Gly Asn Val Asp
Gly Pro Cys Lys
Gly Pro Cys Gln
Gly Pro Lys Cys
Gly Pro Gln Cys
Gly Gln Ala Glu
Gly Gln Cys Pro
Gly Gln Glu Ala
Gly Gln Ile Ser
Gly Gln Leu Ser
Gly Gln Pro Cys
Gly Gln Ser Ile
Gly Gln Ser Leu
Gly Gln Thr Val
Gly Gln Val Thr
Gly Arg Asp Gly
Gly Arg Gly Asp
Gly Ser Ile Gln
Gly Ser Leu Gln
Gly Ser Gln Ile
Gly Ser Gln Leu
Gly Thr Ile Asn
Gly Thr Leu Asn
Gly Thr Asn Ile
Gly Thr Asn Leu
Gly Thr Gln Val
Gly Thr Val Gln
Gly Val Asp Asn
Gly Val Asn Asp
Gly Val Gln Thr
Gly Val Thr Gln
Gly Trp Ala Ala
Ile Ala Asn Ser
Ile Ala Ser Asn
Lys Cys Gly Pro
Lys Cys Pro Gly
Lys Gly Cys Pro
Lys Gly Pro Cys
Lys Pro Cys Gly
Lys Pro Gly Cys
Asn Ala Ala Glu
Asn Ala Cys Pro
Asn Ala Glu Ala
Asn Ala Pro Cys
Asn Cys Ala Pro
Asn Cys Pro Ala
Asn Asp Gly Val
Asn Asp Val Gly
Asn Glu Ala Ala
Asn Gly Asp Val
Asn Gly Val Asp
Asn Pro Ala Cys
Asn Pro Cys Ala
Asn Pro Ser Ser
Asn Ser Pro Ser
Asn Ser Ser Pro
Asn Val Asp Gly
Asn Val Gly Asp
Pro Ala Cys Asn
Pro Ala Asn Cys
Pro Cys Ala Asn
Pro Cys Gly Lys
Pro Cys Gly Gln
Pro Cys Lys Gly
Pro Cys Asn Ala
Pro Cys Gln Gly
Pro Gly Cys Lys
Pro Gly Cys Gln
Pro Gly Lys Cys
Pro Gly Gln Cys
Pro Lys Cys Gly
Pro Lys Gly Cys
Pro Asn Ala Cys
Pro Asn Cys Ala
Pro Asn Ser Ser
Pro Gln Cys Gly
Pro Gln Gly Cys
Pro Ser Asn Ser
Pro Ser Ser Asn
Gln Ala Ala Asp
Gln Ala Asp Ala
Gln Ala Glu Gly
Gln Ala Gly Glu
Gln Cys Gly Pro
Gln Cys Pro Gly
Gln Asp Ala Ala
Gln Glu Ala Gly
Gln Glu Gly Ala
Gln Gly Ala Glu
Gln Gly Cys Pro
Gln Gly Glu Ala
Gln Gly Pro Cys
Gln Pro Cys Gly
Gln Pro Gly Cys
Arg Asp Gly Gly
Arg Gly Asp Gly
Arg Gly Gly Asp
Ser Asn Pro Ser
Ser Asn Ser Pro
Ser Pro Asn Ser
Ser Pro Ser Asn
Ser Ser Asn Pro
Ser Ser Pro Asn
Val Asp Gly Asn
Val Asp Asn Gly
Val Gly Asp Asn
Val Gly Asn Asp
Val Asn Asp Gly
Val Asn Gly Asp
Trp Ala Ala Gly
Trp Ala Gly Ala
Trp Gly Ala Ala
4-amino-5-chloro-N-[1-(cyclohex-3-en-1-ylmethyl)piperidin-4-yl]-2-prop-2-enoxybenzamide
4-([4-(4-Methyloxy-Phenyl)-Piperazin-1-Yl]-Phenyl)-Carbamic Acid Phenyl Ester
N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide
(4-(N-CYCLOHEXYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYL)BORONIC ACID
1-Methyl-3-Octyl-1H-Imidazolium Salt With 2,2,2-Trifluoro-N-(Trifluoroacetyl)Acetamide
ethyl (3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylate
Bambuterol Hydrochloride
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents Bambuterol hydrochloride ((±)-Bambuterol hydrochloride; KWD-2183 hydrochloride) is a long acting beta-adrenoceptor agonist (LABA) used in the treatment of asthma; it also is a proagent of terbutaline.
permafloxacin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic
Rel-N-[4-Methoxy-3-[[[(2R,3R)-2-phenyl-3-piperidinyl]amino]methyl]phenyl]-N-methyl-methanesulfonamide
3H-Indolium, 2-[2-[4-(dimethylamino) phenyl] ethenyl]-1,3,3-trimethyl-, sulfate
Donitriptan
Donitriptan is a potent, high efficacy agonist at 5-HT1B/1D receptors with pKis of 9.4 and 9.3, respectively[1].
(6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2,7-dimethyl-2,3,12,12a-tetrahydropyrazino[1,2:1,6]pyrido[3,4-b]indole-1,4(6H,7H)dione
4-cyano-4-dodecylsulfanylcarbothioylsulfanylpentanoic acid
butyl 2-acetamido-3,4,6-tri-o-acetyl-beta-d-glucopyranoside
Propiverine hydrochloride
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Propiverine hydrochloride is a bladder spasmolytic with calcium antagonistic and anticholinergic properties. Propiverine hydrochloride can be used for the research of overactive blaqdder and urinary incontinence[1][2].
Amibegron
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
N-{5-carbamimidamido-1-[(naphthalen-2-yl)amino]-1-oxopentan-2-yl}benzamide
1-ethyl-N-[3-(4-morpholinyl)propyl]-2-oxo-6-benzo[cd]indolesulfonamide
3-[1-[[1-(4-Methylphenyl)cyclopropyl]-oxomethyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one
6,7-dimethoxy-4-[(3R)-3-(quinoxalin-2-yloxy)pyrrolidin-1-yl]quinazoline
(S)-3-(4-(2-Carbazol-9-YL-ethoxy)-phenyl)-2-ethoxy-propionic acid
(13r,15s)-13-Methyl-16-Oxa-8,9,12,22,24-Pentaazahexacyclo[15.6.2.16,9.1,12,15.0,2,7.0,21,25]heptacosa-1(24),2,4,6,17(25),18,20-Heptaene-23,26-Dione
(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-YL}amino)-3-methylbutan-1-OL
[(4R,4aS,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,5,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] benzoate
N-{3-[(12bs)-7-Oxo-1,3,4,6,7,12b-Hexahydroindolo[2,3-A]quinolizin-12(2h)-Yl]propyl}propane-2-Sulfonamide
(3Z)-3-[(2E,4E,6R)-1-hydroxy-6-[(3R,4R,6S)-6-hydroxy-1,4,8-trimethyl-2,9-dioxabicyclo[3.3.1]non-7-en-3-yl]-4-methylhepta-2,4-dienylidene]pyrrolidine-2,4-dione
6-[(E)-2-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]ethenyl]-4-hydroxyoxan-2-one
2-(3-methylphenoxy)-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]acetamide
Benzatropine mesylate
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators
(10S,15R)-13-Butyl-10-(4-methoxyphenyl)-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
N2,N6-bis[4-(dimethylamino)phenyl]pyridine-2,6-dicarboxamide
4-[[[(1-Ethyl-2-oxo-6-benzo[cd]indolyl)amino]-oxomethyl]amino]benzoic acid ethyl ester
[1-(2-Benzofuranylmethyl)-4-[[3-(trifluoromethyl)phenyl]methyl]-4-piperidinyl]methanol
3,5-Dimethyl-4-isoxazolecarboxylic acid (3-butyl-2,6-dioxo-7-propyl-8-purinyl)methyl ester
4-Ethylbenzoic acid [2-(2-ethoxyanilino)-2-oxo-1-phenylethyl] ester
[3-[(3-Chlorophenyl)methyl]-1-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-3-piperidinyl]methanol
4-[(1-methyl-2-oxo-4-quinolinyl)oxy]-N-[4-(1H-pyrazol-4-yl)-2-pyridinyl]butanamide
3-[4-[(2R,3R,4S)-2-cyano-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-3-azetidinyl]phenyl]-N,N-dimethylbenzamide
3-[4-[(2R,3S,4S)-2-cyano-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-3-azetidinyl]phenyl]-N,N-dimethylbenzamide
3-[4-[(2S,3R,4S)-2-cyano-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-3-azetidinyl]phenyl]-N,N-dimethylbenzamide
3-[4-[(2S,3R,4R)-2-cyano-1-(cyclopropanecarbonyl)-4-(hydroxymethyl)azetidin-3-yl]phenyl]-N,N-dimethylbenzamide
3-[4-[(2S,3S,4S)-2-cyano-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-3-azetidinyl]phenyl]-N,N-dimethylbenzamide
[(1S,2aR,8bR)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-pyridin-4-ylmethanone
[(1R,2aS,8bS)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-pyridin-4-ylmethanone
(6R,7S,8S)-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one
3-[4-[(2S,3S,4R)-2-cyano-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-3-azetidinyl]phenyl]-N,N-dimethylbenzamide
3-[4-[(2R,3R,4R)-2-cyano-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-3-azetidinyl]phenyl]-N,N-dimethylbenzamide
4-[4-[(2S,3R,4R)-2-cyano-1-[cyclopropyl(oxo)methyl]-4-(hydroxymethyl)-3-azetidinyl]phenyl]-N,N-dimethylbenzamide
[(1R,2aR,8bR)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-pyridin-4-ylmethanone
[(1S,2aS,8bS)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-pyridin-4-ylmethanone
(6R,7S,8R)-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8S)-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
6beta-[N-(carboxymethylamino)carbonyl]methoxy-17beta-estradiol
ascochlorin(1-)
A phenolate anion that is the conjugate base of ascochlorin resulting from the deprotonation of the 4-hydroxy group. Major species at pH 7.3.
(1r,9s,16r,19r)-8-acetyl-24-hydroxy-17-methyl-10-oxa-8,17,23-triazahexacyclo[12.6.2.2¹⁶,¹⁹.0¹,⁹.0²,⁷.0¹¹,²¹]tetracosa-2,4,6,11,13,21,23-heptaen-18-one
(2s,3r,7r,9s,10r)-4-methyl-12-oxo-11,16,18-trioxa-4-azapentacyclo[11.7.0.0²,¹⁰.0³,⁷.0¹⁵,¹⁹]icosa-1(20),13,15(19)-trien-9-yl (3r)-3-hydroxybutanoate
(2r,3s,6e,15s,17r)-6-(aminomethylidene)-8,17-dihydroxy-3-(methoxymethyl)-2,15-dimethyl-4-oxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(10),7-diene-5,9,14-trione
(2s,3r,7r,9s,10r)-4-methyl-12-oxo-11,16,18-trioxa-4-azapentacyclo[11.7.0.0²,¹⁰.0³,⁷.0¹⁵,¹⁹]icosa-1(20),13,15(19)-trien-9-yl 3-hydroxybutanoate
4-methyl-12-oxo-11,16,18-trioxa-4-azapentacyclo[11.7.0.0²,¹⁰.0³,⁷.0¹⁵,¹⁹]icosa-1(20),13,15(19)-trien-9-yl 3-hydroxybutanoate
5-chloro-3-(3,5-dimethylhepta-1,3-dien-1-yl)-8-methoxy-7-methyl-6-oxoisoquinolin-7-yl acetate
3,4,11,12-tetramethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-13,16-dione
2'-hydroxystemofoline
{"Ingredient_id": "HBIN005829","Ingredient_name": "2'-hydroxystemofoline","Alias": "NA","Ingredient_formula": "C22H29NO6","Ingredient_Smile": "CCC(CC12C3CCN1C4CC2OC35C4C(C(=C6C(=C(C(=O)O6)C)OC)O5)C)O","Ingredient_weight": "403.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10730","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "139031609","DrugBank_id": "NA"}